Orthofix Medical Inc (OFIX)

Official site

HEALTHCARE • MEDICAL DEVICES • NASDAQ

$7.87

-1.05 (-11.77%)

Market Cap: $360.56M

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

82%(32/39)

Avg Surprise

+79.68%

Streak

16 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$0.11

Range$0.11 - $0.11

1 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$0.08+37.5%

60d ago$0.110.0%

30d ago$0.110.0%

7d ago$0.110.0%

Current$0.11

Revenue Consensus

$211M

Range$210M - $211M

4 analysts

Period ending Dec 31, 2026

EPS Consensus$0.62

Range$0.62 - $0.62

1 analysts

Revenue Consensus

$237M

Range$235M - $238M

4 analysts

Last 12 of 39 reported quarters and 2 upcoming estimates

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.62	$0.62 - $0.62	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	$0.11	$0.11 - $0.11	-	-	1	1 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 5, 2026Reported Aug 5	$-0.39	$-0.46	$-0.46 - $-0.46	+15.22%	Beat	1	1 0 30d	-400.0%
Mar 31, 2026Mar 26 Reported May 5, 2026Reported May 5	$-0.11	N/A	-	+62.07%	Beat	1	No revisions (30d)	-266.7%
Dec 31, 2025Dec 25 Reported Feb 24, 2026Reported Feb 24	$0.24	$-0.22	$-0.24 - $-0.19	+208.09%	Beat	2	1 0 30d	+1444.2%
Sep 30, 2025Sep 25 Reported Nov 4, 2025Reported Nov 4	$0.20	$0.12	$0.12 - $0.12	+66.67%	Beat	1	0 1 30d	+185.7%
Jun 30, 2025Jun 25 Reported Aug 5, 2025Reported Aug 5	$0.13	$0.04	$0.04 - $0.04	+225.00%	Beat	1	No revisions (30d)	+160.0%
Mar 31, 2025Mar 25 Reported May 6, 2025Reported May 6	$-0.03	N/A	-	+88.89%	Beat	3	0 1 30d	-127.3%
Dec 31, 2024Dec 24 Reported Feb 25, 2025Reported Feb 25	$0.02	N/A	-	+130.80%	Beat	3	0 2 30d	-48.7%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$0.07	N/A	-	+146.67%	Beat	3	No revisions (30d)	+0.0%
Jun 30, 2024Jun 24 Reported Aug 6, 2024Reported Aug 6	$0.05	N/A	-	+126.32%	Beat	3	No revisions (30d)	+150.0%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$0.11	N/A	-	+133.33%	Beat	3	No revisions (30d)	+210.0%
Dec 31, 2023Dec 23 Reported Mar 5, 2024Reported Mar 5	$0.03	N/A	-	+137.50%	Beat	4	No revisions (30d)	-84.2%
Sep 30, 2023Sep 23 Reported Nov 8, 2023Reported Nov 8	$0.07	N/A	-	+133.33%	Beat	4	No revisions (30d)	-46.2%

Key Metrics

Valuation
P/E Ratio	-126.53	EV/EBITDA	23.16x
Price/FCF	-11.57x	FCF Yield	-8.64%
Profitability
Profit Margin	-7.41%	Operating Margin	-3.26%
ROE	-13.90%	ROIC	-6.07%
Financial Health
Debt/Equity	0.52x	Interest Coverage	-1.90x
Current Ratio	2.84x	Quick Ratio	1.67x
Trading Statistics
Beta	0.64	Avg Volume	481.74K
52-Week High	$16.42	52-Week Low	$8.50

Technical Indicators Dashboard

Moving Averages

SMA 10$9.29

SMA 20$9.43

SMA 50$9.29

SMA 200$10.97

EMA 10$9.08

EMA 20$9.27

EMA 50$9.49

EMA 200$10.81

MACD

Line: -0.18Signal: -0.02Hist: -0.15

ADX

ADX: 17.8+DI: 22.7-DI: 32.4

Aroon & PSAR

Aroon Up76.0

Aroon Down100.0

PSAR$10.14

Bollinger Bands

Upper Band$10.55

Lower Band$8.31

%B Position2367%(Upper)

Band Width-0.20

RSI (14-Day)

Neutral

35.2

Momentum Oscillators

Stoch %K26.1

Stoch %D26.2

Williams %R-97.8

ROC (10d)-19.8%

Momentum-1.94

CCI (20d)-245.5

MFI (14d)38.6

Volatility Measures

ATR (14d)$0.59(7.5%)

StdDev (20d)0.56

Hist Vol83.1%(High)

Volume Flow

VWAP$8.12

OBV-2.8M

AD Line-7.7M

CMF (20d)-0.113

Volume Metrics

Avg Vol (20d)484.8K

Vol Ratio1.7x(High)

VWMA (20d)$9.29

Pivot Points

R3$11.15

R2$10.60

R1$9.76

Pivot Point$9.20

S1$8.36

S2$7.81

S3$6.97

Advanced Oscillators

TSI-9.22

Ultimate Osc33.8

KST15.09

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$210.93M	$196.71M	$219.91M	$205.63M	$203.12M	$193.65M	$215.66M	$196.61M	$198.62M	$188.61M	$200.41M	$184.01M
Cost of Revenue	$61.23M	$57.16M	$63.57M	$57.11M	$63.59M	$72.03M	$66.82M	$61.55M	$63.87M	$61.37M	$63.78M	$64.24M
Gross Profit	$149.71M	$139.55M	$156.34M	$148.52M	$139.53M	$121.62M	$148.84M	$135.05M	$134.75M	$127.24M	$136.63M	$119.76M

Operating Expenses	$157.84M	$153.98M	$155.85M	$165.57M	$155.54M	$170.49M	$160.32M	$153.95M	$159.66M	$156.58M	$154.94M	$144.21M
R&D	$15.94M	$15.32M	$15.37M	$14.77M	$15.93M	$19.77M	$18.81M	$17.29M	$18.05M	$19.49M	$18.94M	$18.56M
SG&A	$138.03M	$134.91M	$136.75M	$148.10M	$136.49M	$132.98M	$136.48M	$130.14M	$134.22M	$131.69M	$420.27M	$27.14M
Operating Income	$-8,134,000	$-14,436,000	$494,000	$-17,046,000	$-16,003,000	$-48,873,000	$-11,477,000	$-18,899,000	$-24,906,000	$-29,337,000	$-18,315,000	$-24,449,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$6.08M	$5.66M	$4.35M	$4.68M	$3.95M	$4.51M	$14.92M	$5.21M	$4.94M	$4.56M	$4.50M	$1.58M
Income Before Tax	$-14,997,000	$-20,834,000	$-2,192,000	$-22,262,000	$-14,223,000	$-52,133,000	$-29,710,000	$-26,637,000	$-32,359,000	$-35,169,000	$-22,049,000	$-28,385,000
Income Tax Expense	$801,000	$74,000	$30,000	$533,000	$-142,000	$961,000	$-564,000	$751,000	$1.08M	$851,000	$125,000	$472,000

Net Income	$-15,798,000	$-20,908,000	$-2,222,000	$-22,795,000	$-14,081,000	$-53,094,000	$-29,146,000	$-27,388,000	$-33,443,000	$-36,020,000	$-22,174,000	$-28,857,000

EBITDA	$5.45M	$-619,000	$17.21M	$-3,058,000	$7.72M	$-11,945,000	$15.55M	$-1,592,000	$-8,829,000	$-11,224,000	$6.45M	$-4,604,000
EBIT	$-8,912,000	$-15,170,000	$2.16M	$-17,581,000	$-10,273,000	$-47,627,000	$-14,790,000	$-21,427,000	$-27,416,000	$-30,611,000	$-17,549,000	$-26,809,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about OFIX

News

Precision Trading with Orthofix Medical Inc. (OFIX) Risk Zones

This article provides an in-depth analysis of Orthofix Medical Inc. (OFIX) using AI models to generate trading strategies. It highlights near-term weak sentiment testing mid-term strength within a broader long-term weak...

Stock Traders Daily•Nov 2, 2026 3:46 PM ET11/2/26•Neutral

Orthofix Medical | 4: Statement of changes in beneficial ownership of securities-Officer Fisher Patrick

This document is a Statement of changes in beneficial ownership of securities (Form 4) for Orthofix Medical, specifically pertaining to Officer Fisher Patrick. It indicates a change in the beneficial ownership...

Moomoo•Oct 25, 2026 5:11 AM ET10/25/26•Neutral

Orthofix Medical Inc. Estimates – NASDAQ:OFIX

This article provides a link to the financial estimates for Orthofix Medical Inc. (NASDAQ: OFIX) on TradingView. It offers access to reported financial data and analyst estimates across various statements and valuation...

TradingView•Oct 24, 2026 2:41 PM ET10/24/26•Neutral

Investigation launched into Orthofix Medical for possible fiduciary breaches affecting shareholders.

Levi & Korsinsky has initiated an investigation into Orthofix Medical Inc. concerning potential breaches of fiduciary duties...

Pluang•Oct 21, 2026 4:11 PM ET10/21/26•Neutral

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

Levi & Korsinsky, LLP has initiated an investigation into Orthofix Medical Inc. (NASDAQ: OFIX) concerning potential breaches of fiduciary duties by certain officers and directors. Current shareholders of OFIX are...

PR Newswire•Oct 21, 2026 4:11 PM ET10/21/26•Bearish

OFIX Valuation and Fair Value

P/E: -126.5x
Forward P/E: 500.0x
EV/EBITDA: 23.2x
P/FCF: -11.6x
PEG: 48.8x
P/B: 0.8x

See GNG's fair value

OFIX Profitability: Margins, ROIC and FCF

Gross margin: 71.3%
Operating margin: -3.3%
Net margin: -7.4%
ROIC: -6.1%
ROE: -13.9%
FCF yield: -8.6%

OFIX Competitors

Company	Ticker
Fennec Pharmaceuticals Inc	FENC
Zura Bio Limited Class A Ordinary Shares	ZURA
Wellgistics Health, Inc. Common Stock	WGRX
Rezolute Inc	RZLT
Embecta Corp	EMBC
Contineum Therapeutics, Inc. Class A Common Stock	CTNM
Simulations Plus Inc	SLP
Viemed Healthcare Inc	VMD

Sector: Healthcare

OFIX Analyst Ratings

Consensus: Buy
Analysts: 5
Strong Buy: 1
Buy: 2
Hold: 2
Sell: 0
Strong Sell: 0

OFIX Bull Case vs Bear Case

Bull case

OFIX beat EPS estimates in 100.0% of its last 8 reported quarters.
60.0% of OFIX's analyst ratings are Buy or Strong Buy.

Bear case

OFIX has a -7.4% net profit margin.

OFIX Earnings: Beat Rate and Next Report

Beat rate: 8 of 8 quarters (100.0%)
Average surprise: 117.9%
EPS estimate (fiscal period ending Sep 30, 2026): $0.11
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 1 up, 0 down

OFIX Earnings Date

OFIX reports Nov 9, 2026, before the open. The date is confirmed.

OFIX Earnings Call

The latest OFIX earnings call transcript on file is labeled 2026Q2.

Read the 2026Q2 transcript

OFIX ETF Holders

GNG tracks 11 ETFs that hold OFIX. The largest weights:

State Street SPDR S&P Health Care Equipment ETF (XHE), 0.54% of the fund
iShares U.S. Medical Devices ETF (IHI), 0.05% of the fund
iShares Russell 2000 ETF (IWM), 0.04% of the fund
Fidelity Enhanced Small Cap Core ETF (FESM), 0.02% of the fund
Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund

Open the ETF Stock Exposure tool for OFIX

See insider activity

Frequently Asked Questions About OFIX

When does OFIX report earnings?

Orthofix Medical Inc (OFIX) is confirmed to report earnings on Nov 9, 2026.

Does OFIX pay dividends?

Orthofix Medical Inc (OFIX) does not currently pay a regular dividend.

What is OFIX's market cap?

Orthofix Medical Inc (OFIX) has a market capitalization of $360.56M with a current stock price of $7.87.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In